Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
Decoding Estradiol Cypionate: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
26 September 2023
This article summarized the latest R&D progress of Estradiol Cypionate, the Mechanism of Action for Estradiol Cypionate, and the drug target R&D trends for Estradiol Cypionate.
"What" Series
2 min read
What is CRA in Life Sciences?
26 September 2023
The full name is Clinical Research Assistant, who assists the principal investigator in implementing clinical trials according to the trial protocol and GCP.
Drug Insights
4 min read
Deep Scientific Insights on Erythromycin Ethylsuccinate's R&D Progress, Mechanism of Action, and Drug Target
26 September 2023
This article summarized the latest R&D progress of Erythromycin Ethylsuccinate, the Mechanism of Action for Erythromycin Ethylsuccinate, and the drug target R&D trends for Erythromycin Ethylsuccinate.
Valuable Targets
5 min read
Analysis on the Clinical Research Progress of cholesterol drug
26 September 2023
Cholesterol, also known as cholesterin, is a derivative of polycyclic hydrocarbon, widely present in animal bodies, especially abundant in brain and neural tissues.
Drug Insights
4 min read
Duvelisib: Detailed Review of its Transformative R&D Success, Mechanism of Action, and Drug Target
26 September 2023
This article summarized the latest R&D progress of Duvelisib, the Mechanism of Action for Duvelisib, and the drug target R&D trends for Duvelisib.
"What" Series
2 min read
What is a CRO in Life Sciences?
26 September 2023
The full name is Contract Research Organization, which is a contract outsourcing service organization for new drug research and development.
Drug Insights
4 min read
Doxercalciferol Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs, Mechanisms of Action, and Drug Target
26 September 2023
This article summarized the latest R&D progress of Doxercalciferol, the Mechanism of Action for Doxercalciferol, and the drug target R&D trends for Doxercalciferol.
Valuable Targets
6 min read
Analysis on the Research Progress of IL-6 inhibitors
26 September 2023
Interleukin-6 (IL-6) is a 26-kDa secretory protein composed of 184 amino acids and two N-glycosylation sites, as well as four cysteine residues in the mature IL-6.
Drug Insights
3 min read
Unleashing the Power of Cyclopentolate Hydrochloride: A Comprehensive Review on R&D Breakthroughs
26 September 2023
This article summarized the latest R&D progress of Cyclopentolate Hydrochloride, the Mechanism of Action for Cyclopentolate Hydrochloride, and the drug target R&D trends for Cyclopentolate Hydrochloride.
Latest Hotspot
3 min read
Orchard Therapeutics Declares Approval of Biologics License Application for OTL-200 pertaining to MLD
26 September 2023
Orchard Therapeutics, a renowned leader in gene therapy worldwide, reported that the U.S. FDA has approved the submission of their BLA for OTL-200.
Drug Insights
4 min read
A Comprehensive Review of Cyanamide's R&D Innovations and Drug Target Mechanism
26 September 2023
This article summarized the latest R&D progress of Cyanamide, the Mechanism of Action for Cyanamide, and the drug target R&D trends for Cyanamide.
Bio Sequence
2 min read
Gaining the Competitive Edge: Effective Strategies for Patent Retrieval and Analysis of ADC Drugs
26 September 2023
Kadcyla is an antibody-drug conjugate (ADC) used as a single-agent treatment for HER2-positive metastatic breast cancer patients. The article introduces the specific operational methods for patent retrieval of the ADC drug Kadcyla.